UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today announced that ...
ProPhase Labs (PRPH) has initiated a potential sale or strategic partnership process for BE-Smart, its clinically validated esophageal cancer risk stratification test. As part of this process, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results